FLORIDA'S ONLY JOINT COMMISSION-ACCREDITED URGENT CARE
FLORIDA'S ONLY JOINT COMMISSION-ACCREDITED URGENT CARE · ONE OF JUST 8 NATIONWIDE
Influenza A and influenza B produce nearly identical symptoms — sudden-onset fever, body aches, headache, dry cough, sore throat, and profound fatigue — but they differ in how they spread, who they affect most, and how aggressively they circulate each season. Influenza A is responsible for the majority of adult hospitalizations and all historical pandemics; influenza B typically drives a later-season wave and disproportionately affects children. At TrufaMED in Surfside, our multiplex respiratory panel identifies the specific strain within minutes so treatment can begin the same visit.
Influenza A and B are separate genera of the influenza virus family. Both cause seasonal flu, but their biology diverges in clinically meaningful ways:
For the 2025–2026 respiratory season, the CDC reports that H3N2 has been the dominant strain in the southeastern United States, with influenza B/Victoria activity rising through late winter and early spring.
Symptom overlap between the two types is the rule rather than the exception. Both present with an abrupt, rather than gradual, onset:
The classic clinical distinction — that influenza A is always more severe — is an oversimplification. Severe influenza B is well-documented, and every season produces pediatric deaths from both types.
Influenza B tends to produce more gastrointestinal symptoms than influenza A and is associated with a higher rate of myositis (muscle inflammation) in children, which can present as calf pain and difficulty walking. Pediatric patients with influenza B are also at greater risk of developing secondary bacterial otitis media. Adults with influenza B generally recover along the same timeline as influenza A, though elderly patients can still develop viral pneumonia and cardiac complications from either type.
Both types spread through respiratory droplets and close contact. The incubation period is 1 to 4 days (average 2 days), shorter than COVID-19. Patients are contagious from roughly 1 day before symptom onset through 5 to 7 days after, with young children and immunocompromised patients shedding virus longer.
The highest-risk populations are essentially the same for both types:
Most healthy adults recover at home, but you should be evaluated promptly if you experience:
Clinical examination cannot reliably distinguish influenza A from B or from COVID-19, RSV, and strep throat. At TrufaMED, we use a multiplex molecular panel that identifies all four pathogens from a single nasal swab within approximately 20 minutes. Accurate identification directly changes treatment:
Learn more about our combined COVID, flu, strep, and RSV testing panel.
Antiviral therapy is most effective when started within 48 hours of symptom onset. Both influenza A and B respond to the same agents:
Supportive care — hydration, acetaminophen or ibuprofen for fever and body aches, rest — remains essential. Patients with severe dehydration or prolonged fatigue often benefit from IV hydration therapy to accelerate recovery. Our flu treatment protocol is reviewed by a physician at every visit.
Fever typically breaks by day 3 to 5. Cough and fatigue can persist for 1 to 2 weeks. Return to intense exercise should be gradual; influenza-associated myocarditis is rare but well-documented and can be precipitated by premature return to strenuous activity.
The CDC recommends annual influenza vaccination for all patients aged 6 months and older, ideally by the end of October but beneficial throughout the season. The 2025–2026 vaccine is trivalent, targeting H1N1, H3N2, and B/Victoria. Additional prevention measures include hand hygiene, avoiding close contact with symptomatic individuals, and staying home when ill.
Because flu, COVID, RSV, and strep throat can present similarly, particularly early in illness, testing is the only reliable way to confirm the cause. Pediatric patients with influenza-like illness should be evaluated by a clinician experienced in pediatric care; our pediatric urgent care team is available seven days a week.
On average, influenza A causes more severe illness and the majority of adult hospitalizations. However, influenza B can be equally severe in children and in the elderly.
Yes. Because immunity from one type does not protect against the other, back-to-back infections within a single season are well-documented.
Fever usually resolves within 3 to 5 days. Cough and fatigue commonly persist for 1 to 2 weeks. Antivirals can shorten symptoms by 24 to 48 hours if started early.
Yes. The 2025–2026 vaccine covers both influenza A subtypes and influenza B/Victoria.
Ideally within 48 hours of symptom onset. Beyond 48 hours, benefit diminishes but may still be worthwhile in high-risk patients.
Children are more susceptible to influenza B and tend to experience more gastrointestinal symptoms and muscle inflammation than adults.
Yes. Infection with influenza A does not provide cross-protection against influenza B, and strain drift within a single type can also allow reinfection.
If you or a family member has flu-like symptoms, confirming the diagnosis within the first 48 hours is the single most important factor in deciding whether antivirals are appropriate. TrufaMED is open Mon-Fri 9 a.m. to 9 p.m., Sat 11 a.m. to 11 p.m., Sun 12 p.m. to 8 p.m., with a physician on site every day. Walk in at 9445 Harding Avenue in Surfside or call (305) 537-6396 to be seen the same day.
Sources: Centers for Disease Control and Prevention (CDC) FluView weekly surveillance reports. Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines on Seasonal Influenza.